Shin Poong Pharm.Co.Ltd. (019170) - Total Assets

Latest as of December 2025: ₩352.47 Billion KRW ≈ $238.86 Million USD

Based on the latest financial reports, Shin Poong Pharm.Co.Ltd. (019170) holds total assets worth ₩352.47 Billion KRW (≈ $238.86 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Shin Poong Pharm.Co.Ltd. - Total Assets Trend (2003–2025)

This chart illustrates how Shin Poong Pharm.Co.Ltd.'s total assets have evolved over time, based on quarterly financial data. Also see Shin Poong Pharm.Co.Ltd. market cap and net worth for the company's overall valuation and market capitalisation.

Shin Poong Pharm.Co.Ltd. - Asset Composition Analysis

Current Asset Composition (December 2025)

Shin Poong Pharm.Co.Ltd.'s total assets of ₩352.47 Billion consist of 58.7% current assets and 41.4% non-current assets. Review total liabilities of Shin Poong Pharm.Co.Ltd. to assess the company's total debt and financial obligations.

Asset Category	Amount (KRW)	% of Total Assets
Cash & Equivalents	₩0.00	13.5%
Accounts Receivable	₩72.54 Billion	20.6%
Inventory	₩58.48 Billion	16.6%
Property, Plant & Equipment	₩0.00	0.0%
Intangible Assets	₩5.09 Billion	1.4%
Goodwill	₩0.00	0.0%

Asset Composition Trend (2003–2025)

This chart illustrates how Shin Poong Pharm.Co.Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Shin Poong Pharm.Co.Ltd. share price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Shin Poong Pharm.Co.Ltd.'s current assets represent 58.7% of total assets in 2025, an increase from 0.0% in 2003.
Cash Position: Cash and equivalents constituted 13.5% of total assets in 2025, up from 0.9% in 2003.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2003.
Asset Diversification: The largest asset category is accounts receivable at 20.6% of total assets.

Shin Poong Pharm.Co.Ltd. Competitors by Total Assets

Key competitors of Shin Poong Pharm.Co.Ltd. based on total assets are shown below.

Company	Country	Total Assets
Kamada TA:KMDA	Israel	ILA377.21 Million
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Viatris Inc NASDAQ:VTRS	USA	$35.04 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.18 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	China	CN¥10.21 Billion
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	China	CN¥4.49 Billion
Avadel Pharmaceuticals PLC NASDAQ:AVDL	USA	$199.45 Million

Shin Poong Pharm.Co.Ltd. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.09	2.50	4.59
Quick Ratio	2.22	1.77	3.84
Cash Ratio	0.00	0.00	0.00
Working Capital	₩139.83 Billion	₩113.48 Billion	₩248.41 Billion

Shin Poong Pharm.Co.Ltd. - Advanced Valuation Insights

This section examines the relationship between Shin Poong Pharm.Co.Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.19
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	3.0%
Total Assets	₩352.47 Billion
Market Capitalization	$313.87 Million USD

Valuation Analysis

Below Book Valuation: The market values Shin Poong Pharm.Co.Ltd.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Shin Poong Pharm.Co.Ltd.'s assets grew by 3.0% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Shin Poong Pharm.Co.Ltd. (2003–2025)

The table below shows the annual total assets of Shin Poong Pharm.Co.Ltd. from 2003 to 2025.

Year	Total Assets	Change
2025-12-31	₩352.47 Billion ≈ $238.86 Million	+3.03%
2024-12-31	₩342.09 Billion ≈ $231.83 Million	-2.28%
2023-12-31	₩350.08 Billion ≈ $237.25 Million	-3.17%
2022-12-31	₩361.54 Billion ≈ $245.01 Million	-7.91%
2021-12-31	₩392.58 Billion ≈ $266.05 Million	-19.41%
2020-12-31	₩487.15 Billion ≈ $330.13 Million	+28.16%
2019-12-31	₩380.11 Billion ≈ $257.60 Million	-0.22%
2018-12-31	₩380.95 Billion ≈ $258.17 Million	-1.21%
2017-12-31	₩385.61 Billion ≈ $261.32 Million	-7.41%
2016-12-31	₩416.49 Billion ≈ $282.25 Million	+1.40%
2015-12-31	₩410.73 Billion ≈ $278.35 Million	+0.35%
2014-12-31	₩409.30 Billion ≈ $277.37 Million	+2.75%
2013-12-31	₩398.35 Billion ≈ $269.96 Million	+4.92%
2012-12-31	₩379.68 Billion ≈ $257.30 Million	+0.31%
2011-12-31	₩378.50 Billion ≈ $256.50 Million	+17.94%
2010-12-31	₩320.93 Billion ≈ $217.49 Million	+3.48%
2009-12-31	₩310.15 Billion ≈ $210.19 Million	+15.47%
2008-12-31	₩268.61 Billion ≈ $182.03 Million	+23.69%
2007-12-31	₩217.16 Billion ≈ $147.17 Million	+8.00%
2006-12-31	₩201.07 Billion ≈ $136.26 Million	+5.78%
2005-12-31	₩190.07 Billion ≈ $128.81 Million	+8.75%
2004-12-31	₩174.77 Billion ≈ $118.44 Million	+5.16%
2003-12-31	₩166.19 Billion ≈ $112.63 Million	--

About Shin Poong Pharm.Co.Ltd.

KO:019170 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$313.87 Million

₩463.15 Billion KRW

Market Cap Rank

#14694 Global

#465 in Korea

Share Price

₩9400.00

Change (1 day)

+2.17%

52-Week Range

₩7210.00 - ₩15690.00

All Time High

₩197211.54